Insiders · Profile

Beneski Benjamin Machinas

SVP, Chief Technical Officer at Allogene Therapeutics. Filing since 14 Mar 2025. CIK 0002057918

Company
Date
Role
Action
Shares
Amount
Of holding
31 Mar 2026
SVP, Chief Technical Officer
Sold at will
2,867
$7.17K
1.4%
16 Mar 2026
SVP, Chief Technical Officer
Sold at will
4,835
$11.94K
2.4%
2 Mar 2026
SVP, Chief Technical Officer
Sold at will
7,132
$18.54K
3.4%
2 Feb 2026
SVP, Chief Technical Officer
Sold at will
7,549
$13.06K
3.5%
17 Nov 2025
SVP, Chief Technical Officer
Sold at will
786
$958.92
0.4%
14 Mar 2025
SVP, Chief Technical Officer
Sold at will
5,488
$10.84K
2.5%
6 decisions on file.